Literature DB >> 11512587

Divry-Van Bogaert syndrome in a female: relationship to Sneddon's syndrome and radiographic appearances.

J Stone1, J Bhattacharya, T J Walls.   

Abstract

A 28-year-old woman presented with generalised livedo reticularis, dementia, epilepsy, and pyramidal and extrapyramidal signs. Multiple focal infarcts were seen on MRI. Angiography demonstrated widespread cerebromeningeal angiomatosis with multiple small and medium size arterial occlusions. A lifelong personal and family history of mental handicap in the absence of anticardiolipin antibodies suggests Divry-Van Bogaert syndrome, not previously been reported in a female. Similarities to Sneddon's syndrome are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11512587     DOI: 10.1007/s002340000534

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  5 in total

Review 1.  Intracerebral hemorrhage associated with Sneddon's syndrome: is ischemia-related angiogenesis the cause? Case report and review of the literature.

Authors:  F de A Aquino Gondim; R O Leacock; T A Subrammanian; S Cruz-Flores
Journal:  Neuroradiology       Date:  2003-05-16       Impact factor: 2.804

2.  Endovascular Treatment of AVMs in Glasgow.

Authors:  J J Bhattacharya; S Jenkins; P Zampakis; M Behbahani; E Teasdale; V Papanastassiou
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

Review 3.  The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.

Authors:  Markus Kraemer; Dieter Linden; Peter Berlit
Journal:  J Neurol       Date:  2005-08-26       Impact factor: 4.849

4.  Livedo reticularis and related disorders.

Authors:  Steven M Dean
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-04

Review 5.  Sneddon syndrome: under diagnosed disease, complex clinical manifestations and challenging diagnosis. A case-based review.

Authors:  Steve S Kong; Azin Azarfar; Neha Bhanusali
Journal:  Rheumatol Int       Date:  2020-06-12       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.